FDA Warning Letter — Akers Biosciences, Inc.

Case 196333 — FEI 1000121922

The FDA took a Warning Letter action against Akers Biosciences, Inc. on October 4, 2011 (Thorofare, NJ). The action was issued by CBER and concerns biologics products. This facility has 4 recent FDA inspections on record.

Action Details

Facility
Akers Biosciences, Inc.
Date
October 4, 2011
Fiscal Year
2012
Product Type
Biologics
Center
CBER
Location
Thorofare, NJ (United States)